X

Company profile for Cranbury Pharmaceuticals

Cranbury Pharmaceuticals

CRANBURY PHARMACEUTICALS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

Contact Supplier

Related Companies

Cranbury Pharmaceuticals operates as a wholly owned subsidiary of Tris Pharma Inc., an innovative biopharmaceutical company focused on pioneering differentiated approaches to improve therapeutic benefits and optimize patient outcomes. Tris Pharma specializes in addressing conditions such as attention-deficit/hyperactivity disorder (ADHD), pain management, addiction, and diseases affecting the central nervous system (CNS). By l...

Cranbury Pharmaceuticals operates as a wholly owned subsidiary of Tris Pharma Inc., an innovative biopharmaceutical company focused on pioneering differentiated approaches to improve therapeutic benefits and optimize patient outcomes. Tris Pharma specializes in addressing conditions such as attention-deficit/hyperactivity disorder (ADHD), pain management, addiction, and diseases affecting the central nervous system (CNS). By leveraging innovative research and development, Tris Pharma and its subsidiary Cranbury Pharmaceuticals aim to advance treatment options and provide effective solutions for patients in need.